Nick Keher has been dubbed the new Chief Financial Office of Clinigen, replacing Martin Abell who leaves the business in march.
Mr Keher joins from Royal Bank of Canada (RBC) where he was a Managing Director and Head of RBC’s European Healthcare equity research team.
He has covered the European healthcare space for over eight years at both RBC and Investec.
He started his career at Lloyd’s Pharmacy, registering as a pharmacist before joining GlaxoSmithKline (GSK).
At GSK, he worked within the Group’s R&D, UK Commercial Operations and Global Manufacturing & Supply Strategy finance teams where he trained as an accountant.
Shaun Chilton, Group CEO of Clinigen, said: “Nick brings considerable pharmacy and pharmaceutical experience as well as financial expertise, both as an accountant and from working in the financial markets.
“He has a deep knowledge and insight of our business through his research and analysis of Clinigen since its IPO in 2012. He will be a key addition to the executive management team.”